Skip to main content
SpringerLink
Log in

Mycophenolat scheint Azathioprin in der Erhaltungstherapie bei Lupusnephritis überlegen

Mycophenolate mofetil seems to be superior to azothioprine in maintenance therapy of lupus nephritis

  • Klinische Studien kurzgefasst
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus rephritis. N Engl J Med 353:2219–2228

    Article  PubMed  CAS  Google Scholar 

  2. Appel GB, Contreras G, Dooley MA et al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103–1112

    Article  PubMed  CAS  Google Scholar 

  3. Houssiau FA, D’Cruz D, Sangle S et al (2010) Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN. Ann Rheum Dis 69:2083–2089. Nephritis Trial

    Article  PubMed  CAS  Google Scholar 

  4. Tse KC, Tang CS, Lam MF et al (2009) Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis. J Rheumatol 36(1):76–81

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin II (Hämatologie, Onkologie, Immunologie, Rheumatologie, Pulmologie), Medizinische Universitätsklinik, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland

    M. Schmalzing & I. Kötter

Authors
  1. M. Schmalzing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Kötter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Schmalzing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmalzing, M., Kötter, I. Mycophenolat scheint Azathioprin in der Erhaltungstherapie bei Lupusnephritis überlegen. Z. Rheumatol. 71, 813–815 (2012). https://doi.org/10.1007/s00393-012-1022-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-012-1022-8

Search

Navigation